OnKure Therapeutics (OKUR) Change in Cash (2020 - 2026)

OnKure Therapeutics (OKUR) has 7 years of Change in Cash data on file, last reported at $133.1 million in Q1 2026.

• Quarterly Change in Cash rose 1043.66% year-over-year to $133.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $95.4 million (up 23.29% YoY) and the FY2025 annual result came in at -$51.7 million, down 163.93% from the prior year.
• Change in Cash improved to $133.1 million in Q1 2026, from -$11.3 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $133.1 million in Q1 2026 to a low of -$56.1 million in Q3 2022.
• A 5-year average of $4.5 million and a median of -$10.6 million in 2024 frame the typical range for Change in Cash.
• Annual changes were most pronounced in 2022 — Change in Cash slumped 2313.09% — and 2026, when it soared 1043.66%.
• Tracing OKUR's Change in Cash over 5 years: stood at -$42.2 million in 2022, then jumped by 162.84% to $26.5 million in 2023, then soared by 287.6% to $102.8 million in 2024, then tumbled by 110.97% to -$11.3 million in 2025, then surged by 1279.47% to $133.1 million in 2026.
• The last three Change in Cash figures came in at $133.1 million (Q1 2026), -$11.3 million (Q4 2025), and -$13.0 million (Q3 2025), per Business Quant data.